Your browser doesn't support javascript.
loading
The prevalence of genital warts in the Baltic countries: findings from national cross-sectional surveys in Estonia, Latvia and Lithuania.
Uusküla, Anneli; Reile, Rainer; Rezeberga, Dace; Karnite, Anda; Logminiene, Zeneta; Padaiga, Zilvinas; Nygård, Mari.
Afiliação
  • Uusküla A; Department of Public Health, University of Tartu, Tartu, Estonia.
  • Reile R; Department of Public Health, University of Tartu, Tartu, Estonia.
  • Rezeberga D; Department of Obstetrics and Gynecology, Riga Stradins University, Riga, Latvia.
  • Karnite A; Department of Public Health and Epidemiology, Riga Stradins University, Riga, Latvia.
  • Logminiene Z; Department of Preventive Medicine, Lithuanian University of Health Science, Kaunas, Lithuania.
  • Padaiga Z; Department of Preventive Medicine, Lithuanian University of Health Science, Kaunas, Lithuania.
  • Nygård M; Department of Research, Cancer Registry of Norway, Montebello, Oslo, Norway.
Sex Transm Infect ; 91(1): 55-60, 2015 Feb.
Article em En | MEDLINE | ID: mdl-25104496
ABSTRACT

OBJECTIVES:

To assess the prevalence and correlates of self-reported genital warts (GWs) among women and men aged 18-45 years in the Baltic countries.

METHODS:

In 2011-2013 we performed a cross-sectional survey using a self-administered questionnaire to collect information on the history of clinically diagnosed GWs, sociodemographic characteristics and sexual behaviour. Probability sampling methods were used to invite 16,959 individuals representing the general population, of whom 7760 (45.8%) participated (Estonia 1967 women, 1221 men; Latvia 1525 women, 1525 men; Lithuania 1522 women).

RESULTS:

The estimated lifetime prevalence of clinically diagnosed GWs in women was 4.6% (95% CI 3.8 to 5.5) in Estonia, 2.9% (95% CI 2.0 to 3.6) in Latvia and 1.5% (95% CI 1.2 to 2.0) in Lithuania. Among men, the corresponding values were 2.8% (95% CI 1.9 to 4.0) in Estonia and 1.9% (95% CI 1.3 to 2.6) in Latvia. The mean age at first episode of clinically diagnosed GW was 24.6 years (95% CI 23.6 to 25.5) for women and 24.5 years (95% CI 22.9 to 26.0) for men. A lifetime history of clinically diagnosed GW was associated with a history of sexually transmitted infections other than GW (adjusted OR (AOR) 3.0, 95% CI 2.1 to 4.3 for women; AOR 5.3, 95% CI 3.0 to 9.2 for men), and a higher number (5+) of lifetime sexual partners (AOR 2.9, 95% CI 1.9 to 4.2 for women; AOR 2.1, 95% CI 1.2 to 3.9 for men). Men living comfortably within their household income had higher odds for GW (AOR 1.9, 95% CI 1.1 to 3.2).

CONCLUSIONS:

Our estimated prevalence of clinically diagnosed GWs was lower than estimates from the general population of other European countries.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Condiloma Acuminado Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Condiloma Acuminado Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2015 Tipo de documento: Article